BioSpace News Archive

Personalized medicine continues to grow in importance, and having the ability to monitor health data has proven to be a significant desire for people as the number of wearable devices continues to grow.

Software provides an integrated technology platform for adaptive clinical trials

Presentation will highlight data demonstrating the non-sedating effects of tolperisone

Dr. Reddy’s Laboratories Ltd. today announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee

Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation (SFAR) in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ (Oxygen Reserve Index) to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.

Dr. Alberto Siccardi, Medacta’s founder and longtime CEO, will remain President of the company’s Board of Directors

Caris to accelerate development of Next Generation Profiling to analyze whole exome, whole transcriptome and the complete cancer proteome using its proprietary artificial intelligence (AI) analytic engine, DEAN, on tens of thousands of patients with mature clinical outcomes

Effective January 1, 2019, Dr. Albert Bourla to become Chief Executive Officer (CEO) and Ian Read to serve as Executive Chairman of the Board of Directors

ADCETRIS in Combination with Chemotherapy Achieved Primary Endpoint, Demonstrating a Statistically Significant Improvement in Progression-Free Survival Compared to a Standard of Care Chemotherapy

Lannett Company, Inc. today announced that it commenced marketing five new products in its recently completed fiscal 2019 first quarter, bringing to 12 the total number of products launched since January 1, 2018.